| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/08/2001 | WO2001038564A3 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 11/08/2001 | WO2001038558A3 Age-corrected mmp-assay for malignant pathologies |
| 11/08/2001 | WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 11/08/2001 | WO2001033188A8 Assay method for determining product r's effect on adenovirus infection of hela cells |
| 11/08/2001 | WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 11/08/2001 | WO2001029068A3 A eag gene encoding for a potassium channel |
| 11/08/2001 | WO2001023609A3 Hybridization probes which detect bacteria of the genus thermobifida |
| 11/08/2001 | WO2001018240A3 Diagnostic and therapeutic methods in autoimmune disease |
| 11/08/2001 | WO2001018035A3 Muc-1 derived peptides |
| 11/08/2001 | WO2001008707A3 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 11/08/2001 | WO2001002551A3 Virus like particles, preparation and use in screening and functional genomics |
| 11/08/2001 | WO2000079008B1 High throughput assay system |
| 11/08/2001 | WO2000066607A9 Detection using degradation of a tagged sequence |
| 11/08/2001 | WO2000042221A9 Method for the affinity isolation of newly synthesized rna |
| 11/08/2001 | WO2000042209A9 Methods and apparatus for detecting polynucleotide hybridization |
| 11/08/2001 | WO2000002045A3 Bioluminescent assay for agonists or antagonists of a calcium-coupled receptor |
| 11/08/2001 | WO1999051621A3 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 11/08/2001 | US20010039334 Hybrids |
| 11/08/2001 | US20010039072 Reactive probe chip, composite substrate and method for fabrication of the same |
| 11/08/2001 | US20010039057 Devices for testing for the presence and/or concentration of an analyte in a body fluid |
| 11/08/2001 | US20010039040 Electrolytic control of metal ion activity providing a tool for the repetitive isothermal denaturation of duplex DNA and so can be used as a substitute for thermal cycling which allows for a wide range of polymerases to be used |
| 11/08/2001 | US20010039039 Methods for selectively isolating DNA using rolling circle amplification |
| 11/08/2001 | US20010039038 Novel glucosaminidase |
| 11/08/2001 | US20010039035 Enhancing the reaction of a conjugate comprising a detectably labeled phenol substrate with a peroxidase by reacting in the presence of an inorganic compound e.g. NACl, and an organic compound, e.g. p-iodophenol; signal amplification immunoassay |
| 11/08/2001 | US20010039034 Method for labeling individual cells |
| 11/08/2001 | US20010039033 Method and apparatus for detecting microorganisms, and quantities of microorganisms |
| 11/08/2001 | US20010039032 Concurrent determination of micorganism identity; disposable plates and wells inoculated with a microorganism and antibiotic which may be presented a a concentration gradient; urine screening; visability; computers |
| 11/08/2001 | US20010039031 Summarily identifying the species the microorganism belongs to and measuring the minimum inhibitory concentrations of several antimicrobial agents for the microorganism; frequency distribution of minimum inhibitory concentrations; databases |
| 11/08/2001 | US20010039030 Testing the biocidal efficacy of a liquid sterilant using a vessel connected to an inlet and containing a known quantity of microorganisms, the inlet being separated by a porous filter to retain the microbes; disposable syringes |
| 11/08/2001 | US20010039029 To diagnose activity of cancer cells, progress of periodontal diseases, e.g. alveolar pyorrhea, and rheumatoid arthritis; detecting digestion traces on a thin colored membrane contacted with protease-containing tissue or serum |
| 11/08/2001 | US20010039024 Process for identifying and enriching cell-specific target structures |
| 11/08/2001 | US20010039023 Process for identifying cell-specific target structures |
| 11/08/2001 | US20010039022 Quantitative analysis; mesuring pattern of structural changes induced in eukaryotic cells |
| 11/08/2001 | US20010039018 Immobilization of unmodified biopolymers to acyl fluoride activated substrates |
| 11/08/2001 | US20010039017 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 11/08/2001 | US20010039016 Measurement, calibration gene expression |
| 11/08/2001 | US20010039015 Nipple aspirate fluid specific microarrays |
| 11/08/2001 | US20010039014 Integrated systems and methods for diversity generation and screening |
| 11/08/2001 | US20010039013 Screening, diagnosis cancer |
| 11/08/2001 | US20010039012 Analyzing, calibration sample of tissue |
| 11/08/2001 | US20010039008 Immunofluorescence |
| 11/08/2001 | US20010039007 Human t-cell lymphotrophic virus |
| 11/08/2001 | US20010039006 Libraries |
| 11/08/2001 | US20010038845 Parenterally administering large liposomes comprised of phospholipids free of sterol which pick-up cholesterol druing the treatment period; liposomes too large to penetrate fenestrations of endothelial lining hepatic sinusoids |
| 11/08/2001 | US20010038842 Treating a disease characterized by expression of vascular endothelial growth factor-D (VEGF-D) by a tumor by screening for a VEGF-D expressing tumor, administering a VEGF-D antagonist to prevent binding of VEGF-D to its receptor |
| 11/08/2001 | US20010038837 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart |
| 11/08/2001 | US20010038070 Multiplex sequence variation analysis of DNA samples by mass spectrometry |
| 11/08/2001 | EP1144429A3 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 11/08/2001 | DE10106643A1 Detection probes used in bioassays e.g. for determining nucleic acids, based on luminescent doped inorganic nanoparticles which are detectable after irradiation source and can be coupled to affinity molecules |
| 11/08/2001 | DE10021947A1 Detecting nucleic acid by in situ hybridization, useful for detecting microorganisms, with addition of helper probes to increase target accessibility |
| 11/08/2001 | DE10021204A1 Verfahren zur hochparallelen Analyse von Polymorphismen A method for highly parallel analysis of polymorphisms |
| 11/08/2001 | DE10020704A1 Biochip zur Archivierung und labormedizinischen Analyse von biologischem Probenmaterial, Verfahren zu dessen Herstellung sowie dessen Verwendung in diagnostischen Verfahren Biochip for archiving medical and laboratory analysis of biological sample material, process for its preparation and its use in diagnostic methods |
| 11/08/2001 | DE10019289A1 Method for detecting cocoa components in cocoa products, useful e.g. for quality control, comprises amplifying a new husk-specific DNA |
| 11/08/2001 | CA2689946A1 In situ growth, freezing and testing of cultured cells |
| 11/08/2001 | CA2414296A1 Anti-inflammatory compounds and uses thereof |
| 11/08/2001 | CA2414290A1 Anti-inflammatory compounds and uses thereof |
| 11/08/2001 | CA2409686A1 Serine-threonine kinase |
| 11/08/2001 | CA2408263A1 Method and probes for the genetic diagnosis of hemochromatosis |
| 11/08/2001 | CA2408105A1 Novel proteases |
| 11/08/2001 | CA2408094A1 Colloid compositions for solid phase biomolecular analytical, preparative and identification systems |
| 11/08/2001 | CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof |
| 11/08/2001 | CA2408003A1 Gamma secretase substrates and in vitro assays |
| 11/08/2001 | CA2407970A1 A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof |
| 11/08/2001 | CA2407959A1 Human wingless-like gene |
| 11/08/2001 | CA2407906A1 Method for screening agent acting on cell wall |
| 11/08/2001 | CA2407893A1 New gtpase-activating protein 1 |
| 11/08/2001 | CA2407887A1 Natrium-calcium exchanger protein |
| 11/08/2001 | CA2407834A1 Method of identifying agents that alter the activity of the promoter sequence for corticotropin releasing-factor receptor crf 2-alpha |
| 11/08/2001 | CA2407753A1 Method for the detection of minority genomes in virus quasispecies using dna microchips |
| 11/08/2001 | CA2407746A1 Proteases |
| 11/08/2001 | CA2407737A1 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses |
| 11/08/2001 | CA2407731A1 Identification of genetic markers |
| 11/08/2001 | CA2407701A1 Micro-array evanescent wave fluorescence detection device |
| 11/08/2001 | CA2407695A1 Methods for binding an exogenous molecule to cellular chromatin |
| 11/08/2001 | CA2407656A1 Myocardial cell proliferation-associated genes |
| 11/08/2001 | CA2407604A1 Splice variant of camp phosphodiesterase type 7 (pde7a3) |
| 11/08/2001 | CA2407601A1 Novel human phospholipase c delta 5 |
| 11/08/2001 | CA2407460A1 Targeted modification of chromatin structure |
| 11/08/2001 | CA2407435A1 Rna metabolism proteins |
| 11/08/2001 | CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 11/08/2001 | CA2407396A1 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots |
| 11/08/2001 | CA2407272A1 Method and composition for analyzing a carbohydrate polymer |
| 11/08/2001 | CA2407226A1 Polynucleotide probes for detection and quantitation of candida species |
| 11/08/2001 | CA2407219A1 Pain signaling molecules |
| 11/08/2001 | CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 11/08/2001 | CA2406724A1 Device and method for integrated diagnostics with multiple independent flow paths |
| 11/08/2001 | CA2405952A1 Novel assay for nucleic acid analysis |
| 11/08/2001 | CA2405363A1 Epitope synchronization in antigen presenting cells |
| 11/08/2001 | CA2403901A1 29 human secreted proteins |
| 11/08/2001 | CA2324982A1 Method for examining disease |
| 11/07/2001 | EP1152370A2 Control of nucleic acid amplification procedures including the polymerase chain reaction (PCR) |
| 11/07/2001 | EP1152239A1 Biosensor, method of forming thin-film electrode, and method and apparatus for quantitative determination |
| 11/07/2001 | EP1152063A1 Method of diagnosing HBV infection stages |
| 11/07/2001 | EP1152062A2 High temperature reverse transcription using mutant DNA polymerases |
| 11/07/2001 | EP1152061A1 Development of method for screening physiologically active pyrrole imidazole derivative |
| 11/07/2001 | EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof |
| 11/07/2001 | EP1152008A2 Fluorescent nucleotides containing a cyanine, merocyanine or styryl dye for the detection of nucleic acid |
| 11/07/2001 | EP1151306A1 High throughput mass spectrometry |
| 11/07/2001 | EP1151305A1 Prion test |
| 11/07/2001 | EP1151303A1 Screening methods |